Maternal Circulating Vascular Endothelial Growth Factor in Normal Pregnancies and their Relationship to Platelet Counts.
- Author:
Hyun Joo SEOL
1
;
Kyong Wook YI
;
Joo Young MIN
;
Min Jeong OH
;
Hai Joong KIM
;
Jae Kwan LEE
;
Jun Yong HUR
;
Ho Suk SAW
;
Yong Kyun PARK
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Korea University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Vascular endothelial growth factor;
Platelet;
Pregnancy
- MeSH:
Academic Medical Centers;
Blood Platelets*;
Female;
Humans;
Immunoenzyme Techniques;
Korea;
Plasma;
Platelet Count*;
Pregnancy*;
Vascular Endothelial Growth Factor A*
- From:Korean Journal of Obstetrics and Gynecology
2004;47(9):1673-1679
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The aim of the present study was to evaluate changes of vascular endothelial growth factor levels in maternal circulating blood during normal pregnancies and examine their relationship with maternal platelet counts. METHODS: The 33 subjects were selected from healthy normotensive women from the antenatal clinic at Korea University Medical Center, Guro Hospital. Blood samples for VEGF were taken at 7 to 8 weeks' gestation, 16 to 18 weeks' gestation, 24 to 26 weeks' gestation, 30 to 32 weeks' gestation, 37 to 41 weeks' gestation. Serum and plasma were extracted from all samples, and VEGF concentrations were measured in duplicates by competitive enzyme immunoassay. The 23 of them, the platelet counts were performed with an automated blood Coulter counter. RESULTS: Serum VEGF levels during normal pregnancies were mean 6.73 ng/mL at 7-8 weeks' gestation, 7.88 ng/mL at 16-18 weeks' gestation, 7.18 ng/mL at 24-26 weeks' gestation, 8.42 ng/mL at 30-32 weeks' gestation, 14.03 ng/mL at 37-41 weeks' gestation. Plasma VEGF levels were mean 5.50 ng/ mL at 7-8 weeks' gestation, 7.23 ng/mL at 16-18 weeks' gestation, 7.98 ng/mL at 24-26 weeks' gestation, 7.35 ng/mL at 30-32 weeks' gestation, 14.05 ng/mL at 37-41 weeks' gestation. The trends in the mean VEGF levels were similar between serum and plasma, with stable levels until 30 to 32 weeks' gestation, and then the levels were increased. There was no significant difference between serum VEGF levels and plasma VEGF levels (p=0.236) and no correlation between circulating VEGF levels and platelet counts. CONCLUSION: Our data suggests that platelets may not be the origin of elevated VEGF levels in normal pregnancies because there was no correlation between VEGF levels and platelet counts.
